Charles Faith L.
- SEC CIK
- 0001853985
In the past year, 1 open-market purchase filing worth $34.0K and no sales.
Current role at each company
- CNSP CNS Pharmaceuticals, Inc.Directoras of May 20, 2026
- ABEO Abeona Therapeutics Inc.Directoras of Jan 27, 2026
- CDT CDT Equity Inc.Directoras of Apr 17, 2025
- ATXI Avenue Therapeutics, Inc.Directoras of Sep 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $34.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$34.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Charles Faith L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CNSP CNS Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 (view filing) | May 18 | 2 days | Charles Faith L.Director | PPurchase | +7.10K | $4.79 | +$34.0K | New position7.10K after |
ABEO Abeona Therapeutics Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 (view filing) | Jul 9 | 1 day | Charles Faith L.Director | SSale | −10.7K | $5.86 | −$62.9K | −7.2%139.1K after | |
| Apr 29, 2024 (view filing) | Apr 26 | 3 days | Charles Faith L.Director | PPurchase | +7.55K | $3.28 | +$24.8K | +10.7%78.3K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Charles Faith L.Director | SSale | −8.33K | $4.91 | −$40.9K | −10.5%70.8K after |